In vivo modulation of the rat cytochrome P450 1A1 by double-stranded phosphorothioate oligodeoxynucleotides

被引:6
|
作者
Tracewell, W
Desjardins, J
Iversen, P
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACOL,OMAHA,NE 68198
[2] UNIV NEBRASKA,MED CTR,DEPT PHARMACEUT SCI,OMAHA,NE 68198
[3] UNIV NEBRASKA,MED CTR,EPPLEY INST RES CANC,OMAHA,NE 68198
关键词
D O I
10.1006/taap.1995.1221
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CYP1A1 gene expression is regulated by known cis- and transacting elements controlling inhibition and induction of CYP1A1 transcription, The influence of a double-stranded phosphorothioate oligonucleotide (dsODN) with sequence identical to the CYP1A1 negative regulatory element (NRE) was examined in Sprague-Dawley rats. Two strategies were employed: (i) two single-stranded complementary 25-mer ODNs that form a double-stranded ODN (ODN1) and (ii) a 54-base, self-complementary ODN which forms a dsODN hairpin (ODN2). A dsODN hairpin with scrambled NRE sequence was evaluated as a control (ODN3). Zoxazolamine paralysis times, an in vivo marker of CYP1A1 activity, were reduced from 184 +/- 18 min in saline-treated rats to 103 +/- 12.5 min 24 hr after a single 1.7-mg ODN1 iv injection. Liver microsomal EROD, an in vitro marker of CYP1A1/2 activity, was increased from 210 +/- 10 pmol in saline-treated animals to 703 +/- 73 and 623 +/- 89 pmol resorufin/mg protein/min after iv ODN1 and iv ODN2, respectively, ODN1's activity did not change PNP hydroxylation and PROD, markers of CYPs 2E1 and 211 1/2. ODN2 did not significantly change PNP but did significantly alter PROD. The ODN3 did not cause any significant changes in any assay measured, The ODN1-induced responses in ZX paralysis and EROD were observed post-iv injection, but not following ip injection of ODN1. Western blot analysis of ODN1- and HPO-treated rat liver microsomes also revealed increased in CYP1A1 protein. These data indicate double-stranded ODNs mimic the cis-acting NRE in vivo inducing CYP1A1 in the absence of other xenobiotics. (C) 1995 Academic Press, Inc.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 50 条
  • [31] Isolation and sequence analysis of the eel cytochrome P450 1A1 gene
    Aoki, J
    Itakura, T
    Kato, H
    Sato, M
    MARINE BIOTECHNOLOGY, 1999, 1 (04) : 371 - 375
  • [32] Genetic polymorphisms of cytochrome P450 1A1 and risk of gallbladder cancer
    Tsuchiya, Y
    Sato, T
    Kiyohara, C
    Yoshida, K
    Ogoshi, K
    Nakamura, K
    Yamamoto, M
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (01) : 119 - 124
  • [33] The effect of cytochrome b5 on a reaction cycle of cytochrome P450 1A1
    Indra, R.
    Milichovsky, J.
    Moserova, M.
    Arlt, V. M.
    Stiborova, M.
    TOXICOLOGY LETTERS, 2015, 238 (02) : S286 - S286
  • [34] Mercury and methylmercury differentially modulate hepatic cytochrome P450 1A1 and 1A2 in vivo and in vitro
    Alqahtani, Mohammed A.
    El-Ghiaty, Mahmoud A.
    El-Kadi, Ayman O. S.
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2023, 37 (02)
  • [35] Inhibition of the rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo
    Desjardins, JP
    Iversen, PL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 275 (03): : 1608 - 1613
  • [36] Effects of smoking on P-glycoprotein and cytochrome P450 1A1 in human placenta
    Kolwankar, DR
    Glover, DD
    Tracy, TS
    DRUG METABOLISM REVIEWS, 2002, 34 : 88 - 88
  • [37] Interactions among NADPH-cytochrome P450 reductase, P450 1A1, and P4502B4
    Backes, WL
    Cawley, GF
    FASEB JOURNAL, 1999, 13 (05): : A811 - A811
  • [38] Modulation of cytochrome P450 1B1 by tetramethoxystilbene
    Chun, Y. J.
    Oh, Y. K.
    Kim, D.
    Kim, M. Y.
    TOXICOLOGY LETTERS, 2010, 196 : S111 - S111
  • [39] DIFFERENTIAL ROLE IN LIPID-PEROXIDATION BETWEEN RAT P450 1A1 AND P450 1A2
    OHMORI, S
    MISAIZU, T
    NAKAMURA, T
    TAKANO, N
    KITAGAWA, H
    KITADA, M
    BIOCHEMICAL PHARMACOLOGY, 1993, 46 (01) : 55 - 60
  • [40] Induction of cytochrome P450 1A1 by food derived heterocyclic aromatic amines
    Hümmerich, J
    Zohm, C
    Pfau, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R169 - R169